Accolade Investor Presentation Deck

Strong visibility to growth and profitability Targeting $1 billion revenue and 10-15% AEBITDA in FY29 Revenue AEBITDA $363M FY23 (10%) Horizon 1 $410M FY24P (2-4%) ~$500M 2-4% FY25P Horizon 2 20% CAGR FY26-28P $1B+ FY29P ● ● ● ● ● Key drivers Integrated healthcare platform o Advocacy o Primary Care and mental health O Expert Medical Opinion O Trusted Partner Ecosystem Continued market growth, penetration and leadership Increasing revenue-per-customer and net dollar retention Data-driven models achieve scale: Engineered to Care Scale drives margin expansion Accolade ©2023 23

View entire presentation